Clinical Trials
Biohaven Licenses Taldefgrobep Alfa, a Phase 3-Ready Anti-Myostatin Adnectin for Spinal Muscular Atrophy (SMA), from Bristol Myers Squibb
Biohaven Pharmaceutical Holding Company Ltd. announced that it entered into a worldwide license agreement with Bristol Myers Squibb for the development and commercialization rights to taldefgrobep alfa, a novel, Phase 3-ready anti-myostatin adnectin. Taldefgrobep is the third development asset...
News
Mirus Bio Expandes TransIT-VirusGEN SELECT Portfolio with the Addition of Transfection Kits to Increase Titers in Cell and Gene Therapy Manufacturing
Mirus Bio, a leading provider of delivery solutions within Gamma Biosciences, today launched TransIT-VirusGEN® SELECT Transfection Kits for large-scale viral vector production for cell and gene therapy applications. The kits support pre-clinical and process development activities and consist of...
News
Ena Partners With COPD To Develop Pan-Antiviral Nasal Spray
The Chronic Obstructive Pulmonary Disease Foundation, or COPD, has stepped forward to help Ena Respiratory, an Australian clinical-stage pharma company, to develop an antiviral nasal spray targeting chronic lung disease patients. Ena is getting ready to conduct phase 2...
News
How to Treat and Manage Varicose Veins?
Varicose veins are swollen, twisted veins that bulge on the surface of the skin. Many adults in America have them and it is treated as a common condition around the world.
Several experts and research institutions often consider them as...
News
Varicose Veins: What Is It, Treatments and Medications
Varicose veins are a common problem among adults in America. In fact, approximately 24% of adults living in America have visible varicose veins.
With that, many patients are now turning to surgeons and vein specialists to have them removed. There...
News
To Vote On Vaccine Pricing, Pfizer To Join J&J And Moderna
It's no secret that pharmaceutical companies have been criticised for their unequal access to COVID-19 vaccines. Oxfam has won several battles to obtain pricing and intellectual property information from Johnson & Johnson, Pfizer, and Moderna.
Shareholders of J&J will have an...
News
Singapore Drug Guard Gets World’s First WHO Maturity Level
Singapore is the first country in WHO's categorization of regulatory authority for medical goods to obtain the highest maturity level (ML 4) out of 28 nations formally examined. With ML 4, Singapore is one step closer to being a...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read